Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT)

Author： Cho D.   Di Blasio C.J.   Rhee A.C.   Kattan M.W.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.4, 2003-07, pp. : 282-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the androgen receptor in hormone-refractory prostate cancer – new concepts

By Eder Iris E   Haag Petra   Bartsch Georg   Klocker Helmut  

Future Oncology, Vol. 1, Iss. 1, 2005-02 ,pp. : 93-101

Future Medicine

Access to resources Recommend Favorite

The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 3, 2007-11 ,pp. : 203-211

Bentham Science Publishers

Access to resources Recommend Favorite

Living alone, obesity and smoking: Important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer

By Dieperink Karin B.   Hansen Steinbjørn   Wagner Lis   Johansen Christoffer   Andersen Klaus K.   Hansen Olfred  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 722-729

Informa Healthcare

Access to resources Recommend Favorite

Intermittent Androgen Deprivation Therapy in Advanced Prostate Cancer

By Alva Ajjai   Hussain Maha  

Current Treatment Options in Oncology, Vol. 15, Iss. 1, 2014-03 ,pp. : 127-136

Springer Publishing Company

Access to resources Recommend Favorite

Management Strategies for Hormone-Refractory Prostate Cancer

By Attard Gerhardt   de Bono Johann S.   Parker Christopher C.   Horwich Alan  

American Journal of Cancer, Vol. 5, Iss. 3, 2006-01 ,pp. : 163-169

Adis International

Access to resources Recommend Favorite